Lassman, Andrew, Pugh, Stephanie, Wang, Tony
et al. (2019). ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM)
.
NEURO-ONCOLOGY, 21(Supplement_6), vi17-vi17. 10.1093/neuonc/noz175.064
Lassman, Andrew, Pugh, Stephanie, Wang, Tony et al. (2019). ACTR-21. A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 3 TRIAL OF DEPATUXIZUMAB MAFODOTIN (ABT-414) IN EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AMPLIFIED (AMP) NEWLY DIAGNOSED GLIOBLASTOMA (nGBM)
. NEURO-ONCOLOGY, 21(Supplement_6), vi17-vi17. 10.1093/neuonc/noz175.064